Patents by Inventor Kazuki Yasuda
Kazuki Yasuda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250071224Abstract: An image reading apparatus includes a transparent member including a document placing surface on which a document is placed, a document pressing portion that presses the document placed on the transparent member against the transparent member, a pivot supporting portion that pivotably supports the document pressing portion so as to be pivotable about a pivot shaft with respect to a casing of the image reading apparatus, an image reading unit, an abutment portion against which an edge portion of the document placed on the document placing surface is abutted in order to position the document at a reference position, and an inclined surface. The abutment portion is provided at one portion of a front end on a side far from the pivot supporting portion. The inclined surface is provided at another portion of the front end and inclined upward toward the side far from the pivot supporting portion.Type: ApplicationFiled: November 7, 2024Publication date: February 27, 2025Inventors: TAKAHIRO ONO, TAKAYUKI FUKUSHIMA, KAZUKI MATSUO, YUYA YASUDA, TAKUMA TACHIBANA, AKIYUKI MITAMURA, AKIRA MATSUMOTO, AKIRA URITA, NORIKAZU HISHINUMA, TAKATSUGU NAKAMURA, YU HASHIMOTO
-
Publication number: 20250031810Abstract: A slide fastener with which a slide fastener-attached product capable of preventing or suppressing exposure of a fastener tape can be manufactured is provided. The slide fastener includes fastener stringers and a slider, in which each of fastener elements includes an element base portion and a fin portion extending from the element base portion toward a tape inner side of a fastener tape and having a smaller dimension in a tape thickness direction than the element base portion, in which, at a shoulder-port-side end portion of a slider body, a leading end portion of the fin portion of each of the fastener elements is positioned on the outer side of the slider body with respect to an inner wall surface of a flange, and in which the ratio of a total fin width to an element maximum width is less than 40%.Type: ApplicationFiled: June 6, 2024Publication date: January 30, 2025Inventors: Yoshiyuki Sho, Nao Yasuda, Takayoshi Tanaka, Tomoya Kaido, Yoshifumi Nakata, Yutaka Sunagawa, Kazuki Katsuki
-
Publication number: 20250039316Abstract: A document supporting portion includes a first supporting portion and a second supporting portion. The first supporting portion has a first supporting surface that supports a document. The second supporting portion has a second supporting surface that supports the document together with the first supporting surface and provided so as to be slidable between a first position at which the second supporting portion located above the first supporting portion and a second position at which the second supporting surface supports the document together with the first supporting surface. In a state where the second supporting portion is located at the first position, the second supporting surface constitutes a portion of an upper surface of the document feeding apparatus.Type: ApplicationFiled: October 11, 2024Publication date: January 30, 2025Inventors: TAKAHIRO ONO, TAKAYUKI FUKUSHIMA, KAZUKI MATSUO, YUYA YASUDA, TAKUMA TACHIBANA, AKIYUKI MITAMURA, AKIRA MATSUMOTO, AKIRA URITA, NORIKAZU HISHINUMA, TAKATSUGU NAKAMURA, YU HASHIMOTO
-
Publication number: 20150057335Abstract: [PROBLEMS] To identify mutations that can serve as indicators for predicting the effectiveness of drug treatments in cancers such as lung cancer; to provide a means for detecting said mutations; and to provide a means for identifying, based on said mutations, patients with cancer or subjects with a risk of cancer, in which drugs targeting genes having said mutations or proteins encoded by said genes show a therapeutic effect. [MEANS FOR SOLVING] A method for detecting a gene fusion serving as a responsible mutation (driver mutation) for cancer, the method comprising the step of detecting any one of an EZR-ERBB4 fusion polynucleotide, a KIAA1468-RET fusion polynucleotide, a TRIM24-a BRAF fusion polynucleotide, a CD74-NRG1 fusion polynucleotide, and an SLC3A2-NRG1 fusion polynucleotide, or a polypeptide encoded thereby, in an isolated sample from a subject with cancer.Type: ApplicationFiled: August 20, 2014Publication date: February 26, 2015Inventors: Takashi Kohno, Koji Tsuta, Kazuki Yasuda
-
Publication number: 20110151456Abstract: The present invention relates to a method of testing for genetic susceptibility to type-2 diabetes in a subject that comprises detecting one or more polymorphisms present in the KCNQ1 gene and/or EIF2AK4 gene in a DNA-containing sample collected from the subject. The present invention permit a method of accurately, conveniently, and rapidly testing the genetic susceptibility of subjects to type-2 by targeting determinative genetic factors of genetic susceptibility to type-2 diabetes.Type: ApplicationFiled: December 15, 2008Publication date: June 23, 2011Applicants: National Center for Global Health and Medicine, The University of Tokyo, National University Corporation Ehime UniversityInventors: Kazuki Yasuda, Masato Kasuga, Takashi Kadowaki, Hiroto Furuta, Hideichi Makino, Naoko Iwasaki, Yukio Horikawa, Kazuya Yamagata, Yoshitomo Oka
-
Patent number: 7235366Abstract: The invention relates generally to compositions of and methods for obtaining opioid receptor polypeptides. The invention relates as well to polynucleotides encoding opioid receptor polypeptides, the recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant opioid receptor polypeptides. By way of example, the invention discloses the cloning and functional expression of at least three different opioid receptor polypeptides. The invention includes as well, methods for using the isolated, recombinant receptor polypeptides in assays designed to select and improve substances capable of interacting with opioid receptor polypeptides for use in diagnostic, drug design and therapeutic applications.Type: GrantFiled: May 31, 1995Date of Patent: June 26, 2007Assignee: ARCH Development CorporationInventors: Graeme I. Bell, Terry Reisine, Kazuki Yasuda
-
Publication number: 20030211537Abstract: The invention relates generally to compositions of and methods for obtaining opioid receptor polypeptides. The invention relates as well to polynucleotides encoding opioid receptor polypeptides, the recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant opioid receptor polypeptides. By way of example, the invention discloses the cloning and functional expression of at least three different opioid receptor polypeptides. The invention includes as well, methods for using the isolated, recombinant receptor polypeptides in assays designed to select and improve substances capable of interacting with opioid receptor polypeptides for use in diagnostic, drug design and therapeutic applications.Type: ApplicationFiled: October 21, 2002Publication date: November 13, 2003Applicant: Arch Development CorporationInventors: Graeme I. Bell, Terry Reisine, Kazuki Yasuda
-
Patent number: 6319686Abstract: The invention relates generally to compositions of and methods for obtaining opioid receptor polypeptides. The invention relates as well to polynucleotides encoding opioid receptor polypeptides. More specifically, the invention relates to polynucleotides encoding kappa opioid receptor polypeptides, the recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant opioid receptor polypeptides. By way of example, the invention discloses the cloning and functional expression of at least three different opioid receptor polypeptides. The invention includes as well, methods for using the isolated, recombinant receptor polypeptides in assays designed to select and improve substances capable of interacting with opioid receptor polypeptides for use in diagnostic, drug design and therapeutic applications.Type: GrantFiled: August 19, 1994Date of Patent: November 20, 2001Assignee: Arch Development CorporationInventors: Graeme I. Bell, Terry Reisine, Kazuki Yasuda
-
Patent number: 6096513Abstract: The invention relates generally to compositions of and methods for using polynucleotides encoding kappa opioid receptors. In addition to such polynucleotides themselves, the invention relates to expression vectors comprising polynucleotides encoding kappa opioid receptors, recombinant host cells comprising such polynucleotides, and processes for preparing kappa opioid receptor polypeptides.Type: GrantFiled: November 5, 1993Date of Patent: August 1, 2000Assignee: Arch Development CorporationInventors: Graeme I. Bell, Terry Reisine, Kazuki Yasuda
-
Patent number: 5541060Abstract: The invention relates to the observed tight linkage between DNA polymorphisms in the glucokinase gene (GCK) on the short arm of chromosome 7, and NIDDM in a cohort of sixteen French families having MODY. It further relates to identification of mutations in GCK and their linkage with diabetes in particular families are disclosed. This invention provides the first evidence implicating specific mutations in a gene involved in glucose metabolism in the pathogenesis of NIDDM. The invention further discloses the isolation and characterization of human pancreatic .beta.-cell GCK and a method for searching for mutations that cause early-onset NIDDM. To assess the effect of these mutations on glucokinase activity, a method is disclosed for generating an .alpha.-carbon backbone model for human glucokinase based on the crystal structure of the structurally-related yeast hexokinase B.Type: GrantFiled: April 22, 1992Date of Patent: July 30, 1996Assignee: Arch Development CorporationInventors: Graeme I. Bell, Markus Stoffel, Jun Takeda, Nathalie Vionnet, Kazuki Yasuda, Simon J. Pilkis, Habib Zouali, Gilberto Velho, Daniel Cohen, Philippe Froguel